Five years of caplacizumab – lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpura
Linus Alexander Völker, Paul T. Brinkkoetter, Spero R. Cataland, Camila Masias
Topics & Concepts
MedicineADAMTS13RegimenThrombotic thrombocytopenic purpuraContext (archaeology)RituximabIntensive care medicineInternal medicineImmunologyPediatricsPlateletLymphomaBiologyPaleontologyComplement system in diseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaRenal Diseases and Glomerulopathies